1.Symptomatic Aerophagia in a Patient using Long-term Noninvasive Positive Pressure Ventilation.
Baik Kyun KIM ; Soo Yeon KIM ; Jin Hong SHIN ; Dae Seong KIM
Korean Journal of Clinical Neurophysiology 2015;17(2):101-102
No abstract available.
Humans
;
Positive-Pressure Respiration*
2.Clinical applications of noninvasive positive pressure mechanical ventilation technology.
Chinese Journal of Medical Instrumentation 2005;29(5):368-370
This article expounds the types, applicable diseases and medical departments of noninvasive positive pressure mechanical ventilators and the problems we should pay attention to while using them.
Humans
;
Positive-Pressure Respiration
3.Application of positive end expiratory pressure during laparoscopic surgery.
Korean Journal of Anesthesiology 2013;65(3):193-194
No abstract available.
Laparoscopy
;
Positive-Pressure Respiration
4.Measurement of Auto-PEEP.
Tuberculosis and Respiratory Diseases 2004;57(6):522-527
No abstract available.
Positive-Pressure Respiration, Intrinsic*
5.LMA with positive pressure ventilation is safe!.
Nicole RIEM ; Sylvain BOET ; Laurent TRITSCH ; Dylan BOULD
Korean Journal of Anesthesiology 2011;61(1):88-89
No abstract available.
Positive-Pressure Respiration
6.In vitro activity of cefepime against aerobic gram-negative bacilli and gram-positive cocci.
Wan Sik SHIN ; Jin Hong YOO ; Kyung Shil PARK ; Hwang CHOI ; Hyung Kyoo YOON ; Yung Shin SHIN ; Yang Lee KIM ; Moon Won KANG
Korean Journal of Infectious Diseases 1993;25(4):363-368
No abstract available.
Gram-Positive Cocci*
7.Noninvasive Positive Pressure Ventilation.
The Korean Journal of Critical Care Medicine 1997;12(1):1-4
No abstract available.
Positive-Pressure Respiration*
8.Noninvasive Positive Pressure Ventilation.
The Korean Journal of Critical Care Medicine 2002;17(1):5-11
No abstract available.
Positive-Pressure Respiration*
9.A REVIEW ON CD88-EXPRESSING IMMUNE CELLS AND THEIR INFLUENCE ON ATHEROSCLEROSIS
Muhammad Hayatuddeen Rumah ; Ida Shazrina Ismail ; Rafeezul Mohamed ; Muhammad Amir Yunus
Journal of University of Malaya Medical Centre 2022;25(SPECIAL ISSUE):90-101
CD88, which stands for "Cluster of Differentiation 88," is also known as C5aR, which stands for "Complement 5a receptor." This complement receptor has 7 transmembrane domains and is found on various cell types, including monocytes, macrophages, dendritic cells, epithelial cells, adipocytes, and endothelial cells. Atherosclerosis is a condition associated with chronic inflammation of the arterial walls. It's marked by lipid retention and building, monocyte and T lymphocyte recruitment into the intima, foam cell generation, smooth muscle cell proliferation, and collagen and protein accumulation. C5a has been found in a wide range of atherosclerotic lesions, from fatty streaks to advanced plaques. The expression of CD88 has been linked to both proatherogenic and antiatherogenic effects in atherosclerosis. Initial activities of C5a in atherosclerosis include chemotaxis, oxidative burst, and vascular adhesion molecule activation. CD88 expression has also been linked to the formation of atherosclerosis plaques via adaptive immune cell activation. Regulation and effector functions require ligand-receptor binding (C5a-C5aR) in the pathogenesis of atherosclerosis. CD88 expression has been linked to all stages of atherosclerosis. Myeloid cells have been identified to express CD88, which is responsible for many of C5a's biological properties. During atherogenesis, macrophages and dendritic cells are two important antigen presentation cells (APCs) that carry and display the CD88 surface marker. The proliferation and division of CD4+ T helper cells are controlled by macrophages, dendritic cells, and mast cells, which are also responsible for the release of both proatherogenic and antiatherogenic cytokines. However, there is no evidence that naive CD4+ T helper cells express CD88 from any of the research that has been done. Since CD88 is expressed by a wide variety of immune cells in atherosclerotic plaques, including macrophages, dendritic cells, T lymphocytes, and B lymphocytes, this review will focus on the influence of CD88 expressing immune cells in atherosclerosis formation.
CD4-Positive T-Lymphocytes
10.Clinical efficacy of teicoplanin in gram-positive bacterial infection.
Kang Hyun CHOI ; Jae Hoon SONG ; Koo Yung CHO ; Hyung Ho KIM ; Bin YOO ; Chul Won SUH
Korean Journal of Infectious Diseases 1993;25(1):57-62
No abstract available.
Gram-Positive Bacterial Infections*
;
Teicoplanin*